{ "labelLang" : "hun", "responseDate" : "2024-03-28 10:27", "content" : { "otype" : "JournalArticle", "mtid" : 33789335, "status" : "APPROVED", "published" : true, "unhandledTickets" : 0, "deleted" : false, "lastRefresh" : "2024-03-01T07:38:36.067+0000", "lastModified" : "2023-11-15T12:15:41.953+0000", "created" : "2023-05-03T10:07:35.971+0000", "creator" : { "otype" : "Admin", "mtid" : 10067747, "link" : "/api/admin/10067747", "label" : "Reményiné Kállai Zsuzsa (DE admin 4)", "familyName" : "Reményiné Kállai", "givenName" : "Zsuzsa", "published" : true, "snippet" : true }, "lastDuplumOK" : "2023-12-12T18:35:53.197+0000", "lastDuplumSearch" : "2023-12-12T18:35:53.197+0000", "core" : true, "citation" : true, "publicationPending" : false, "type" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "subType" : { "otype" : "SubType", "mtid" : 1134514, "link" : "/api/subtype/1134514", "label" : "Összefoglaló cikk (Folyóiratcikk)", "name" : "Összefoglaló cikk", "nameEng" : "Survey paper", "docType" : { "otype" : "PublicationType", "mtid" : 24, "link" : "/api/publicationtype/24", "label" : "Folyóiratcikk", "code" : 24, "otypeName" : "JournalArticle", "listPosition" : 1, "published" : true, "oldId" : 24, "snippet" : true }, "listPosition" : 102, "published" : true, "oldId" : 1134514, "snippet" : true }, "category" : { "otype" : "Category", "mtid" : 1, "link" : "/api/category/1", "label" : "Tudományos", "published" : true, "oldId" : 1, "snippet" : true }, "languages" : [ { "otype" : "Language", "mtid" : 10002, "link" : "/api/language/10002", "label" : "Angol", "name" : "Angol", "nameEng" : "English", "published" : true, "oldId" : 2, "snippet" : true } ], "firstAuthor" : "Képes, Zita", "authorships" : [ { "otype" : "PersonAuthorship", "mtid" : 107565093, "link" : "/api/authorship/107565093", "label" : "Képes, Zita ✉ [Képes, Zita (Dr Képes Zita), szerző] Orvosi Képalkotó Intézet (DE / ÁOK); Nukleáris Medicina Tanszék (DE / ÁOK / OKI)", "listPosition" : 1, "share" : 0.25, "first" : true, "last" : false, "corresponding" : true, "author" : { "otype" : "Author", "mtid" : 10077392, "link" : "/api/author/10077392", "label" : "Képes Zita (Dr Képes Zita)", "familyName" : "Képes", "givenName" : "Zita", "published" : true, "snippet" : true }, "familyName" : "Képes", "givenName" : "Zita", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 107565094, "link" : "/api/authorship/107565094", "label" : "Hajdu, István [Hajdu, István (Nukleáris medicin...), szerző] Nukleáris Medicina Tanszék (DE / ÁOK / OKI)", "listPosition" : 2, "share" : 0.25, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10035948, "link" : "/api/author/10035948", "label" : "Hajdu István (Nukleáris medicina, Radiokémia, Nanotechnológia)", "familyName" : "Hajdu", "givenName" : "István", "published" : true, "oldId" : 10035948, "snippet" : true }, "familyName" : "Hajdu", "givenName" : "István", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 107565095, "link" : "/api/authorship/107565095", "label" : "Fenyvesi, Ferenc [Fenyvesi, Ferenc (Gyógyszerészeti t...), szerző] Gyógyszertechnológiai Tanszék (DE / GYTK); Gyógyszerésztudományi Kar (DE)", "listPosition" : 3, "share" : 0.25, "first" : false, "last" : false, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10013800, "link" : "/api/author/10013800", "label" : "Fenyvesi Ferenc (Gyógyszerészeti tudományok)", "familyName" : "Fenyvesi", "givenName" : "Ferenc", "published" : true, "oldId" : 10013800, "snippet" : true }, "familyName" : "Fenyvesi", "givenName" : "Ferenc", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true }, { "otype" : "PersonAuthorship", "mtid" : 107565096, "link" : "/api/authorship/107565096", "label" : "Trencsényi, György [Trencsényi, György (Nukleáris medicin...), szerző] Nukleáris Medicina Tanszék (DE / ÁOK / OKI)", "listPosition" : 4, "share" : 0.25, "first" : false, "last" : true, "corresponding" : false, "author" : { "otype" : "Author", "mtid" : 10027698, "link" : "/api/author/10027698", "label" : "Trencsényi György (Nukleáris medicina, preklinikai képalkotás, kísérletes onkológia)", "familyName" : "Trencsényi", "givenName" : "György", "published" : true, "oldId" : 10027698, "snippet" : true }, "familyName" : "Trencsényi", "givenName" : "György", "authorTyped" : true, "editorTyped" : false, "otherTyped" : false, "type" : { "otype" : "AuthorshipType", "mtid" : 1, "link" : "/api/authorshiptype/1", "label" : "Szerző", "code" : 0, "published" : true, "oldId" : 0, "snippet" : true }, "published" : false, "snippet" : true } ], "title" : "Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era", "identifiers" : [ { "otype" : "PublicationIdentifier", "mtid" : 23477056, "link" : "/api/publicationidentifier/23477056", "label" : "DOI: 10.1016/j.ijpharm.2023.122978", "source" : { "otype" : "PlainSource", "mtid" : 6, "link" : "/api/publicationsource/6", "label" : "DOI", "type" : { "otype" : "PublicationSourceType", "mtid" : 10001, "link" : "/api/publicationsourcetype/10001", "label" : "DOI", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "DOI", "nameEng" : "DOI", "linkPattern" : "https://doi.org/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 6, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "10.1016/j.ijpharm.2023.122978", "realUrl" : "https://doi.org/10.1016/j.ijpharm.2023.122978", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 24376620, "link" : "/api/publicationidentifier/24376620", "label" : "REAL: 173703", "source" : { "otype" : "SwordSource", "mtid" : 36, "link" : "/api/publicationsource/36", "label" : "REAL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10007, "link" : "/api/publicationsourcetype/10007", "label" : "Repozitórium", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "REAL", "nameEng" : "REAL", "linkPattern" : "http://real.mtak.hu/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 36, "snippet" : true }, "oaType" : "GOLD", "oaFree" : true, "idValue" : "173703", "realUrl" : "http://real.mtak.hu/173703", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 24793044, "link" : "/api/publicationidentifier/24793044", "label" : "WoS: 001004374000001", "source" : { "otype" : "PlainSource", "mtid" : 1, "link" : "/api/publicationsource/1", "label" : "WoS", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "WoS", "nameEng" : "WoS", "linkPattern" : "https://www.webofscience.com/wos/woscc/full-record/@@@", "publiclyVisible" : true, "published" : true, "oldId" : 1, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "001004374000001", "realUrl" : "https://www.webofscience.com/wos/woscc/full-record/001004374000001", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 24721986, "link" : "/api/publicationidentifier/24721986", "label" : "Scopus: 85159054100", "source" : { "otype" : "PlainSource", "mtid" : 3, "link" : "/api/publicationsource/3", "label" : "Scopus", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "Scopus", "linkPattern" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@", "publiclyVisible" : true, "published" : true, "oldId" : 3, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "85159054100", "realUrl" : "http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85159054100", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 24721987, "link" : "/api/publicationidentifier/24721987", "label" : "PubMed: 37121492", "source" : { "otype" : "PlainSource", "mtid" : 17, "link" : "/api/publicationsource/17", "label" : "PubMed", "type" : { "otype" : "PublicationSourceType", "mtid" : 10003, "link" : "/api/publicationsourcetype/10003", "label" : "Indexelő adatbázis", "mayHaveOa" : false, "published" : true, "snippet" : true }, "name" : "PubMed", "nameEng" : "PubMed", "linkPattern" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract", "publiclyVisible" : true, "published" : true, "oldId" : 17, "snippet" : true }, "validState" : "IDENTICAL", "idValue" : "37121492", "realUrl" : "http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37121492&dopt=Abstract", "published" : false, "snippet" : true }, { "otype" : "PublicationIdentifier", "mtid" : 23477057, "link" : "/api/publicationidentifier/23477057", "label" : "Egyéb URL: https://linkinghub.elsevier.com/retrieve/pii/S0378517323003988", "source" : { "otype" : "PlainSource", "mtid" : 40, "link" : "/api/publicationsource/40", "label" : "Egyéb URL", "type" : { "otype" : "PublicationSourceType", "mtid" : 10006, "link" : "/api/publicationsourcetype/10006", "label" : "Link", "mayHaveOa" : true, "published" : true, "snippet" : true }, "name" : "Egyéb URL", "nameEng" : "Other URL", "linkPattern" : "@@@", "publiclyVisible" : true, "published" : true, "oldId" : 40, "snippet" : true }, "idValue" : "https://linkinghub.elsevier.com/retrieve/pii/S0378517323003988", "realUrl" : "https://linkinghub.elsevier.com/retrieve/pii/S0378517323003988", "published" : false, "snippet" : true } ], "journal" : { "otype" : "Journal", "mtid" : 2083, "link" : "/api/journal/2083", "label" : "INTERNATIONAL JOURNAL OF PHARMACEUTICS 0378-5173 1873-3476", "pIssn" : "0378-5173", "eIssn" : "1873-3476", "reviewType" : "REVIEWED", "noIF" : false, "sciIndexed" : true, "scopusIndexed" : true, "lang" : "FOREIGN", "hungarian" : false, "published" : true, "oldId" : 2083, "snippet" : true }, "volume" : "640", "internalId" : "122978", "firstPageOrInternalIdForSort" : "122978", "publishedYear" : 2023, "abstractText" : "As malignancies remain one of the major health concerns worldwide, increasing focus has been centered around the application of cyclodextrins (CDs) in cancer imaging and therapy due to their outstanding inclusion forming capability. Albeit the physicochemical properties of CDs were intensively elucidated, the spread of their clinical application is limited by the relative paucity of knowledge about their pharmacokinetic profile, especially biodistribution. Studies applying fluorescently- CDs, or CD-based MRI contrast agents revealed much about pharmacokinetics and diagnostic applications; however, derivatives labelled with positron emitters seem superior molecular probes in the investigation of the route of CDs in biological niche. In vivo imaging based on preclinical tumor-bearing model systems are well-suited to evaluate the whole-body distribution of the two most frequently assessed CDs: randomly methylated ?-cyclodextrin (RAMEB), and hydroxypropyl-?-cyclodextrin (HPBCD). Exploiting the firm signaling interaction between cancer-related cyclooxygenase-2, prostaglandin E2 (PGE2) and RAS oncoprotein, radioconjugated, PGE2-affine CDs project the establishment of novel imaging probes and therapeutic agents. Currently, we provide an overview of the preclinical studies on CD pharmacokinetics highlighting the significance of the integration of translational discoveries into human patient care.", "digital" : null, "printed" : true, "sourceYear" : 2023, "foreignEdition" : true, "foreignLanguage" : true, "fullPublication" : true, "conferencePublication" : false, "nationalOrigin" : true, "missingAuthor" : false, "oaType" : "GOLD", "oaCheckDate" : "2024-03-01", "oaFree" : true, "oaLink" : "http://real.mtak.hu/173703", "citationCount" : 2, "citationCountUnpublished" : 0, "citationCountWoOther" : 2, "independentCitCountWoOther" : 2, "nationalOriginCitationCount" : 0, "foreignEditionCitationCount" : 2, "doiCitationCount" : 2, "wosCitationCount" : 2, "scopusCitationCount" : 1, "wosScopusCitationCount" : 2, "wosScopusCitationCountWoOther" : 2, "wosScopusIndependentCitationCount" : 2, "wosScopusIndependentCitationCountWoOther" : 2, "independentCitationCount" : 2, "selfCitationCount" : 0, "unhandledCitationCount" : 0, "citingPubCount" : 2, "independentCitingPubCount" : 2, "citingPubCountWoOther" : 2, "independentCitingPubCountWoOther" : 2, "unhandledCitingPubCount" : 0, "citedPubCount" : 14, "citedCount" : 14, "pubStats" : { "types" : [ { "type" : "Folyóiratcikk", "typeEng" : "Journal Article", "code" : 24, "count" : 2 }, { "type" : "Könyvrészlet", "typeEng" : "Chapter in Book", "code" : 25, "count" : 0 }, { "type" : "Könyv", "typeEng" : "Book", "code" : 23, "count" : 0 }, { "type" : "Egyéb konferenciaközlemény", "typeEng" : "Conference paper", "code" : 31, "count" : 0 }, { "type" : "Egyéb konferenciakötet", "typeEng" : "Conference proceedings", "code" : 32, "count" : 0 }, { "type" : "Oltalmi formák", "typeEng" : "Protection forms", "code" : 26, "count" : 0 }, { "type" : "Disszertáció", "typeEng" : "Thesis", "code" : 28, "count" : 0 }, { "type" : "Egyéb", "typeEng" : "Miscellaneous", "code" : 29, "count" : 0 }, { "type" : "Alkotás", "typeEng" : "Achievement", "code" : 22, "count" : 0 }, { "type" : "Kutatási adat", "typeEng" : "Research data", "code" : 33, "count" : 0 } ], "citationTypes" : [ { "type" : "Folyóiratcikk", "typeEng" : "Journal Article", "code" : 24, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Könyvrészlet", "typeEng" : "Chapter in Book", "code" : 25, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Könyv", "typeEng" : "Book", "code" : 23, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb konferenciaközlemény", "typeEng" : "Conference paper", "code" : 31, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb konferenciakötet", "typeEng" : "Conference proceedings", "code" : 32, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Oltalmi formák", "typeEng" : "Protection forms", "code" : 26, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Disszertáció", "typeEng" : "Thesis", "code" : 28, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Egyéb", "typeEng" : "Miscellaneous", "code" : 29, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Alkotás", "typeEng" : "Achievement", "code" : 22, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 }, { "type" : "Kutatási adat", "typeEng" : "Research data", "code" : 33, "countUnknown" : 0, "countIndependent" : 0, "countSelfCitation" : 0 } ], "years" : [ { "year" : 2023, "publicationCount" : 0, "citationCount" : 2, "independentCitationCount" : 2, "citingPubCount" : 2, "independentCitingPubCount" : 2, "oaStats" : null, "oaStats2" : null } ] }, "ratings" : [ { "otype" : "SjrRating", "mtid" : 11405919, "link" : "/api/sjrrating/11405919", "label" : "sjr:D1 (2023) Scopus - Pharmaceutical Science INTERNATIONAL JOURNAL OF PHARMACEUTICS 0378-5173 1873-3476", "listPos" : 18, "rankValue" : 0.1, "type" : "journal", "ratingType" : { "otype" : "RatingType", "mtid" : 10002, "link" : "/api/ratingtype/10002", "label" : "sjr", "code" : "sjr", "published" : true, "snippet" : true }, "subject" : { "otype" : "ClassificationExternal", "mtid" : 3003, "link" : "/api/classificationexternal/3003", "label" : "Scopus - Pharmaceutical Science", "published" : true, "oldId" : 3003, "snippet" : true }, "ranking" : "D1", "calculation" : "FROM_LAST_YEAR", "published" : true, "snippet" : true } ], "ratingsForSort" : "D1", "references" : [ { "otype" : "Reference", "mtid" : 40934253, "link" : "/api/reference/40934253", "label" : "1. Adeoye, O., Cabral-Marques H. 2017. Cyclodextrin nanosystems in oral drug delivery: A mini review. Int. J. Pharm. 531, 521-531. https://doi.org/ 10.1016/j.ijpharm.2017.04.050., DOI: 10.1016/j.ijpharm.2017.04.050", "listPosition" : 1, "doi" : "10.1016/j.ijpharm.2017.04.050", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934254, "link" : "/api/reference/40934254", "label" : "2. Ahenkorah 2021: Bismuth-213 for Targeted Radionuclide Therapy: From Atom to Bedside., Pharmaceutics., 13, p. 599, DOI: 10.3390/pharmaceutics13050599", "listPosition" : 2, "doi" : "10.3390/pharmaceutics13050599", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934255, "link" : "/api/reference/40934255", "label" : "3. Aime 1991: Inclusion complexes between β-cyclodextrin and β-benzyloxy-α-propionic derivatives of paramagnetic DOTA- and DPTA-Gd(III) complexes., Magn. Reson. Chem., 29, p. 923, DOI: 10.1002/mrc.1260290910", "listPosition" : 3, "doi" : "10.1002/mrc.1260290910", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934256, "link" : "/api/reference/40934256", "label" : "4. Akkın 2022: A different approach to immunochemotherapy for colon Cancer: Development of nanoplexes of cyclodextrins and Interleukin-2 loaded with 5-FU., Int. J. Pharm., 623, DOI: 10.1016/j.ijpharm.2022.121940", "listPosition" : 4, "doi" : "10.1016/j.ijpharm.2022.121940", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934257, "link" : "/api/reference/40934257", "label" : "5. Allport 2001: In vivo imaging of gene and cell therapies., Exp. Hematol., 29, p. 1237, DOI: 10.1016/S0301-472X(01)00739-1", "listPosition" : 5, "doi" : "10.1016/S0301-472X(01)00739-1", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934258, "link" : "/api/reference/40934258", "label" : "6. Ameli 2022: Targeted delivery of capecitabine to colon cancer cells using nano polymeric micelles based on beta cyclodextrin., RSC. Adv., 12, p. 4681, DOI: 10.1039/D1RA07791K", "listPosition" : 6, "doi" : "10.1039/D1RA07791K", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934259, "link" : "/api/reference/40934259", "label" : "7. Backlund 2006: Ras up-regulation of cyclooxygenase-2., Methods. Enzymol., 407, p. 401, DOI: 10.1016/S0076-6879(05)07033-3", "listPosition" : 7, "doi" : "10.1016/S0076-6879(05)07033-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934260, "link" : "/api/reference/40934260", "label" : "8. Barge 2007: New CD derivatives as self-assembling contrast agents for magnetic resonance imaging (MRI)., J. Incl. Phenom. Macrocycl. Chem., 57, p. 489, DOI: 10.1007/s10847-006-9239-2", "listPosition" : 8, "doi" : "10.1007/s10847-006-9239-2", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934261, "link" : "/api/reference/40934261", "label" : "9. Bellringer 1995: beta-Cyclodextrin: 52-week toxicity studies in the rat and dog., Food. Chem. Toxicol., 33, p. 367, DOI: 10.1016/0278-6915(94)00149-I", "listPosition" : 9, "doi" : "10.1016/0278-6915(94)00149-I", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934262, "link" : "/api/reference/40934262", "label" : "10. Benkovics 2017: The ‘Visualized’ macrocycles: Chemistry and application of fluorophore tagged cyclodextrins., Int. J. Pharm., 531, p. 689, DOI: 10.1016/j.ijpharm.2017.04.035", "listPosition" : 10, "doi" : "10.1016/j.ijpharm.2017.04.035", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934263, "link" : "/api/reference/40934263", "label" : "11. Bicknese 1992: Single photon radioluminescence. I., Theory and spectroscopic properties. Biophys. J., 63, p. 1256", "listPosition" : 11, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934264, "link" : "/api/reference/40934264", "label" : "12. Bryson 2008: Reineke TM. A beta-cyclodextrin “click cluster” decorated with seven paramagnetic chelates containing two water exchange sites., Bioconjug. Chem., 19, p. 1505, DOI: 10.1021/bc800200q", "listPosition" : 12, "doi" : "10.1021/bc800200q", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934265, "link" : "/api/reference/40934265", "label" : "13. Carmona 2015: Soluble cyanine dye/β-cyclodextrin derivates: potential carriers for drug delivery and optical imaging., Dyes. Pigm., 114, p. 204, DOI: 10.1016/j.dyepig.2014.11.014", "listPosition" : 13, "doi" : "10.1016/j.dyepig.2014.11.014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934266, "link" : "/api/reference/40934266", "label" : "14. Chakravarty 2013: Detailed evaluation on the effect of metal ion impurities on complexation of generator eluted 68Ga with different bifunctional chelators., Nucl. Med. Biol., 40, p. 197, DOI: 10.1016/j.nucmedbio.2012.11.001", "listPosition" : 14, "doi" : "10.1016/j.nucmedbio.2012.11.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934267, "link" : "/api/reference/40934267", "label" : "15. Chaves 2011: A gallium complex with a new tripodal tris-hydroxypyridinone for potential nuclear diagnostic imaging: solution and in vivo studies of 67Ga-labeled species., J. Inorg. Biochem., 105, p. 31, DOI: 10.1016/j.jinorgbio.2010.09.012", "listPosition" : 15, "doi" : "10.1016/j.jinorgbio.2010.09.012", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934268, "link" : "/api/reference/40934268", "label" : "16. Clarke 1991: Stabilities of trivalent metal ion complexes of the tetraacetate derivatives of 12-, 13- and 14-membered tetraazamacrocycles., Inorganica. Chimica. Acta., 1, p. 37, DOI: 10.1016/S0020-1693(00)80229-7", "listPosition" : 16, "doi" : "10.1016/S0020-1693(00)80229-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934269, "link" : "/api/reference/40934269", "label" : "17. Csige 2022: In vivo investigation of Gallium-68 and Bismuth-205/206 labeled beta cyclodextrin for targeted alpha therapy of prostaglandin E2 receptor-expressing tumors in mice., Int. J. Pharm., 625, DOI: 10.1016/j.ijpharm.2022.122132", "listPosition" : 17, "doi" : "10.1016/j.ijpharm.2022.122132", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934270, "link" : "/api/reference/40934270", "label" : "18. Cunha 2014: Preclinical imaging: an essential ally in modern biosciences., Mol. Diagn. Ther., 18, p. 153, DOI: 10.1007/s40291-013-0062-3", "listPosition" : 18, "doi" : "10.1007/s40291-013-0062-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934271, "link" : "/api/reference/40934271", "label" : "19. De Bie 1998: Disposition of [14C]gamma-cyclodextrin in germ-free and conventional rats., Regul. Toxicol. Pharmacol., 27, p. 150, DOI: 10.1006/rtph.1998.1219", "listPosition" : 19, "doi" : "10.1006/rtph.1998.1219", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934272, "link" : "/api/reference/40934272", "label" : "20. Dekempeneer 2016: Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle., Expert. Opin. Biol. Ther., 16, p. 1035, DOI: 10.1080/14712598.2016.1185412", "listPosition" : 20, "doi" : "10.1080/14712598.2016.1185412", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934273, "link" : "/api/reference/40934273", "label" : "21. Dekempeneer 2020: Therapeutic Efficacy of 213Bi-labeled sdAbs in a Preclinical Model of Ovarian Cancer., Mol. Pharm., 17, p. 3553, DOI: 10.1021/acs.molpharmaceut.0c00580", "listPosition" : 21, "doi" : "10.1021/acs.molpharmaceut.0c00580", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934274, "link" : "/api/reference/40934274", "label" : "22. Del Valle 2004: Cyclodextrins and their uses: A review., Process. Biochem., 39, p. 1033, DOI: 10.1016/S0032-9592(03)00258-9", "listPosition" : 22, "doi" : "10.1016/S0032-9592(03)00258-9", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934275, "link" : "/api/reference/40934275", "label" : "23. Díaz-Moscoso 2010: Insights in cellular uptake mechanisms of pDNA-polycationic amphiphilic cyclodextrin nanoparticles (CDplexes)., J. Control. Release., 143, p. 318, DOI: 10.1016/j.jconrel.2010.01.016", "listPosition" : 23, "doi" : "10.1016/j.jconrel.2010.01.016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934276, "link" : "/api/reference/40934276", "label" : "24. Downward 2003: Targeting RAS signalling pathways in cancer therapy., Nat. Rev. Cancer., 3, p. 11, DOI: 10.1038/nrc969", "listPosition" : 24, "doi" : "10.1038/nrc969", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934277, "link" : "/api/reference/40934277", "label" : "25. El-Darzi 2021: Pikuleva IA. 2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1-/- Cyp46a1-/- mice with deficiency in the oxysterol production., Br. J. Pharmacol., 178, p. 3220, DOI: 10.1111/bph.15209", "listPosition" : 25, "doi" : "10.1111/bph.15209", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934278, "link" : "/api/reference/40934278", "label" : "26. Feng 2017: Neodymium-doped NaHoF4 nanoparticles as near-infrared luminescent/T2-weighted MR dual-modal imaging agents in vivo., J. Mater. Chem. B., 5, p. 504, DOI: 10.1039/C6TB01961G", "listPosition" : 26, "doi" : "10.1039/C6TB01961G", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934279, "link" : "/api/reference/40934279", "label" : "27. Fenyvesi 2014: Fluorescently labeled methyl-beta-cyclodextrin enters intestinal epithelial Caco-2 cells by fluid-phase endocytosis., PLoS One., 9, p. e84856, DOI: 10.1371/journal.pone.0084856", "listPosition" : 27, "doi" : "10.1371/journal.pone.0084856", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934280, "link" : "/api/reference/40934280", "label" : "28. Frank 1976: Cyclodextrin nephrosis in the rat., Am. J. Pathol., 83, p. 367", "listPosition" : 28, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934281, "link" : "/api/reference/40934281", "label" : "29. Frijlink 1990: The pharmacokinetics of beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin in the rat., Pharm. Res., 7, p. 1248, DOI: 10.1023/A:1015929720063", "listPosition" : 29, "doi" : "10.1023/A:1015929720063", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934282, "link" : "/api/reference/40934282", "label" : "30. Frijlink 1991: The effect of parenterally administered cyclodextrins on cholesterol levels in the rat., Pharm. Res., 8, p. 9, DOI: 10.1023/A:1015861719134", "listPosition" : 30, "doi" : "10.1023/A:1015861719134", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934283, "link" : "/api/reference/40934283", "label" : "31. Fromming 1993: Pharmacokinetics and toxicology of cyclodextrins.Topics in inclusion science, Cyclodextrins in Pharmacy, p. 33", "listPosition" : 31, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934284, "link" : "/api/reference/40934284", "label" : "32. Fukaura 2021: Intracerebroventricular Treatment with 2-Hydroxypropyl-β-Cyclodextrin Decreased Cerebellar and Hepatic Glycoprotein Nonmetastatic Melanoma Protein B (GPNMB) Expression in Niemann-Pick Disease Type C Model Mice., Int. J. Mol. Sci., 22, p. 452, DOI: 10.3390/ijms22010452", "listPosition" : 32, "doi" : "10.3390/ijms22010452", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934285, "link" : "/api/reference/40934285", "label" : "33. Gao 2022: Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis., J. Control. Release., 349, p. 2, DOI: 10.1016/j.jconrel.2022.06.053", "listPosition" : 33, "doi" : "10.1016/j.jconrel.2022.06.053", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934286, "link" : "/api/reference/40934286", "label" : "34. Gerloczy 1990: Absorption, distribution and excretion of 14-C; labelled HP-β-CD in rats following oral administration.Minutes of the 5th International Symposium on Cyclodextrins, p. 507", "listPosition" : 34, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934287, "link" : "/api/reference/40934287", "label" : "35. Gerlóczy 1985: Absorption, distribution, excretion and metabolism of orally administered 14C-beta-cyclodextrin in rat., Arzneimittelforschung., 35, p. 1042", "listPosition" : 35, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934288, "link" : "/api/reference/40934288", "label" : "36. Godwin 1962: Half-life of Radiocarbon., Nature., 195, p. 984, DOI: 10.1038/195984a0", "listPosition" : 36, "doi" : "10.1038/195984a0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934289, "link" : "/api/reference/40934289", "label" : "37. Gould 2005: 2-Hydroxypropyl-beta-cyclodextrin (HP-beta-CD): a toxicology review., Food. Chem. Toxicol., 43, p. 1451, DOI: 10.1016/j.fct.2005.03.007", "listPosition" : 37, "doi" : "10.1016/j.fct.2005.03.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934290, "link" : "/api/reference/40934290", "label" : "38. Hajdu 2019: Radiochemical synthesis and preclinical evaluation of 68Ga-labeled NODAGA-hydroxypropyl-beta-cyclodextrin (68Ga-NODAGA-HPBCD)., Eur. J. Pharm. Sci., 128, p. 202, DOI: 10.1016/j.ejps.2018.12.001", "listPosition" : 38, "doi" : "10.1016/j.ejps.2018.12.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934291, "link" : "/api/reference/40934291", "label" : "39. Hakim 2021: Methyl-Beta-Cyclodextrin Restores KIR Channel Function in Brain Endothelium of Female Alzheimer's Disease Mice., J. Alzheimers. Dis. Rep., 5, p. 693, DOI: 10.3233/ADR-210016", "listPosition" : 39, "doi" : "10.3233/ADR-210016", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934292, "link" : "/api/reference/40934292", "label" : "40. Halpern 1977: Chemical and biological consequences of beta-decay. Part 1., Radiat. Environ. Biophys., 14, p. 167, DOI: 10.1007/BF01323937", "listPosition" : 40, "doi" : "10.1007/BF01323937", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934293, "link" : "/api/reference/40934293", "label" : "41. Han 2019: Hypoxia-targeting dendritic MRI contrast agent based on internally hydroxy dendrimer for tumor imaging., Biomaterials., 213, DOI: 10.1016/j.biomaterials.2019.05.006", "listPosition" : 41, "doi" : "10.1016/j.biomaterials.2019.05.006", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934294, "link" : "/api/reference/40934294", "label" : "42. Hasegawa 2009: A highly sensitive probe detecting low pH area of HeLa cells based on rhodamine B modified beta-cyclodextrins., Bioorg. Med. Chem., 17, p. 6015, DOI: 10.1016/j.bmc.2009.06.046", "listPosition" : 42, "doi" : "10.1016/j.bmc.2009.06.046", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934295, "link" : "/api/reference/40934295", "label" : "43. Heng 1997: A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells., Gastroenterology., 113, p. 1883, DOI: 10.1016/S0016-5085(97)70007-6", "listPosition" : 43, "doi" : "10.1016/S0016-5085(97)70007-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934296, "link" : "/api/reference/40934296", "label" : "44. Hoang 2006: Oncogenic RAS mutations in myeloma cells selectively induce cox-2 expression, which participates in enhanced adhesion to fibronectin and chemoresistance., Blood., 107, p. 4484, DOI: 10.1182/blood-2005-09-3926", "listPosition" : 44, "doi" : "10.1182/blood-2005-09-3926", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934297, "link" : "/api/reference/40934297", "label" : "45. Hoh Kam 2015: Topical cyclodextrin reduces amyloid beta and inflammation improving retinal function in ageing mice., Exp. Eye. Res., 135, p. 59, DOI: 10.1016/j.exer.2015.03.023", "listPosition" : 45, "doi" : "10.1016/j.exer.2015.03.023", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934298, "link" : "/api/reference/40934298", "label" : "46. Inoue 2022: Multifunctional Therapeutic Cyclodextrin-Appended Dendrimer Complex for Treatment of Systemic and Localized Amyloidosis., ACS. Appl. Mater. Interfaces., 14, p. 40599, DOI: 10.1021/acsami.2c09913", "listPosition" : 46, "doi" : "10.1021/acsami.2c09913", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934299, "link" : "/api/reference/40934299", "label" : "47. National Cancer Institute at the National Institute of Health USA, 2020. Cancer statistics. https://www.cancer.gov/about-cancer/understanding/statistics", "listPosition" : 47, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934300, "link" : "/api/reference/40934300", "label" : "48. Jansook 2018: Cyclodextrins: Structure, physicochemical properties and pharmaceutical applications., Int. J. Pharm., 535, p. 272, DOI: 10.1016/j.ijpharm.2017.11.018", "listPosition" : 48, "doi" : "10.1016/j.ijpharm.2017.11.018", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934301, "link" : "/api/reference/40934301", "label" : "49. Kantner 2012: Long-term parenteral administration of 2-hydroxypropyl-β-cyclodextrin causes bone loss., Toxicol. Pathol., 40, p. 742, DOI: 10.1177/0192623312441405", "listPosition" : 49, "doi" : "10.1177/0192623312441405", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934302, "link" : "/api/reference/40934302", "label" : "50. Karthic 2022: Cyclodextrin nanoparticles for diagnosis and potential cancer therapy: A systematic review., Front. Cell. Dev. Biol., 10, DOI: 10.3389/fcell.2022.984311", "listPosition" : 50, "doi" : "10.3389/fcell.2022.984311", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934303, "link" : "/api/reference/40934303", "label" : "51. Kilsdonk, E.P., Yancey, P.G., Stoudt, G.W. et al. 1995. Cellular cholesterol efflux mediated by cyclodextrins. J. Biol. Chem. 270, 17250-17256. https://doi.org/ 10.1074/jbc.270.29.17250., DOI: 10.1074/jbc.270.29.17250", "listPosition" : 51, "doi" : "10.1074/jbc.270.29.17250", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934304, "link" : "/api/reference/40934304", "label" : "52. Kiss 2010: Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: Evidence for the role of cholesterol extraction., Eur. J. Pharm. Sci., 40, p. 376, DOI: 10.1016/j.ejps.2010.04.014", "listPosition" : 52, "doi" : "10.1016/j.ejps.2010.04.014", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934305, "link" : "/api/reference/40934305", "label" : "53. Koo 2017: Development and application of cyclodextrin hydrolyzing mutant enzyme which hydrolyzes β-and γ-CD selectively., J. Agric. Food. Chem., 65, p. 2331, DOI: 10.1021/acs.jafc.7b00269", "listPosition" : 53, "doi" : "10.1021/acs.jafc.7b00269", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934306, "link" : "/api/reference/40934306", "label" : "54. Kotková 2010: Cyclodextrin-based bimodal fluorescence/MRI contrast agents: an efficient approach to cellular imaging., Chemistry., 16, p. 10094, DOI: 10.1002/chem.200903519", "listPosition" : 54, "doi" : "10.1002/chem.200903519", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934307, "link" : "/api/reference/40934307", "label" : "55. Kotková 2012: Gadolinium complexes of monophosphinic acid DOTA derivatives conjugated to cyclodextrin scaffolds: efficient MRI contrast agents for higher magnetic fields., Dalton. Trans., 41, p. 13509, DOI: 10.1039/c2dt30858d", "listPosition" : 55, "doi" : "10.1039/c2dt30858d", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934308, "link" : "/api/reference/40934308", "label" : "56. Kumar 2016: Evaluation of a PACAP Peptide Analogue Labeled with (68)Ga Using Two Different Chelating Agents., Cancer. Biother. Radiopharm., 31, p. 29", "listPosition" : 56, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934309, "link" : "/api/reference/40934309", "label" : "57. Lachowicz 2020: Characteristic of Cyclodextrins: Their Role and Use in the Pharmaceutical Technology., Curr. Drug. Targets., 21, p. 1495, DOI: 10.2174/1389450121666200615150039", "listPosition" : 57, "doi" : "10.2174/1389450121666200615150039", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934310, "link" : "/api/reference/40934310", "label" : "58. Lahrech 2008: Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent., J. Cereb. Blood. Flow. Metab., 28, p. 1017, DOI: 10.1038/sj.jcbfm.9600602", "listPosition" : 58, "doi" : "10.1038/sj.jcbfm.9600602", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934311, "link" : "/api/reference/40934311", "label" : "59. Lipinski 2001: Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings., Adv. Drug. Deliv. Rev., 46, p. 3, DOI: 10.1016/S0169-409X(00)00129-0", "listPosition" : 59, "doi" : "10.1016/S0169-409X(00)00129-0", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934312, "link" : "/api/reference/40934312", "label" : "60. Liu 2012: Multifunctional pH-disintegrable micellar nanoparticles of asymmetrically functionalized β-cyclodextrin-based star copolymer covalently conjugated with doxorubicin and DOTA-Gd moieties., Biomaterials., 33, p. 2521, DOI: 10.1016/j.biomaterials.2011.12.013", "listPosition" : 60, "doi" : "10.1016/j.biomaterials.2011.12.013", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934313, "link" : "/api/reference/40934313", "label" : "61. Loftsson 1996: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization., J. Pharm. Sci., 85, p. 1017, DOI: 10.1021/js950534b", "listPosition" : 61, "doi" : "10.1021/js950534b", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934314, "link" : "/api/reference/40934314", "label" : "62. Loftsson 2005: Cyclodextrins in drug delivery., Expert. Opin. Drug. Deliv., 2, p. 335, DOI: 10.1517/17425247.2.1.335", "listPosition" : 62, "doi" : "10.1517/17425247.2.1.335", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934315, "link" : "/api/reference/40934315", "label" : "63. Loftsson 2007: Effects of cyclodextrins on drug delivery through biological membranes., J. Pharm. Sci., 96, p. 2532, DOI: 10.1002/jps.20992", "listPosition" : 63, "doi" : "10.1002/jps.20992", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934316, "link" : "/api/reference/40934316", "label" : "64. Loftsson 2019: Self-association of cyclodextrins and cyclodextrin complexes in aqueous solutions., Int. J. Pharm., 560, p. 228, DOI: 10.1016/j.ijpharm.2019.02.004", "listPosition" : 64, "doi" : "10.1016/j.ijpharm.2019.02.004", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934317, "link" : "/api/reference/40934317", "label" : "65. Loo 2011: In situ detection of apoptosis by the TUNEL assay: an overview of techniques., Methods. Mol. Biol., 682, p. 3, DOI: 10.1007/978-1-60327-409-8_1", "listPosition" : 65, "doi" : "10.1007/978-1-60327-409-8_1", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934318, "link" : "/api/reference/40934318", "label" : "66. Mathias, C.J., Lewis, M.R., Reichert, D.E., et al. 2003. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl. Med. Biol. 2003, 30, 725-731. https://doi.org/ 10.1016/s0969-8051(03)00080-5., DOI: 10.1016/S0969-8051(03)00080-5", "listPosition" : 66, "doi" : "10.1016/S0969-8051(03)00080-5", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934319, "link" : "/api/reference/40934319", "label" : "67. Matilainen 2008: In vitro toxicity and permeation of cyclodextrins in Calu-3 cells., J. Control. Release., 126, p. 10, DOI: 10.1016/j.jconrel.2007.11.003", "listPosition" : 67, "doi" : "10.1016/j.jconrel.2007.11.003", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934320, "link" : "/api/reference/40934320", "label" : "68. Monbaliu 1990: Disposition of HP-β-CD in experimental animals.Minutes of the 5th International Symposium on Cyclodextrins, p. 514", "listPosition" : 68, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934321, "link" : "/api/reference/40934321", "label" : "69. Morgenstern 2012: Bismuth-213 and actinium-225 – generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes., Curr. Radiopharm., 5, p. 221, DOI: 10.2174/1874471011205030221", "listPosition" : 69, "doi" : "10.2174/1874471011205030221", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934322, "link" : "/api/reference/40934322", "label" : "70. Mourtzis 2008: Synthesis, characterization, and remarkable biological properties of cyclodextrins bearing guanidinoalkylamino and aminoalkylamino groups on their primary side., Chemistry., 14, p. 4188, DOI: 10.1002/chem.200701650", "listPosition" : 70, "doi" : "10.1002/chem.200701650", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934323, "link" : "/api/reference/40934323", "label" : "71. Nakagami, A., Mao, Q., Gouhier, G. et al. 2021. FRET-Based In-Cell Detection of Highly Selective Supramolecular Complexes of meso-Tetraarylporphyrin with Peptide/BODIPY-Modified Per-O-Methyl-β-Cyclodextrins. Chembiochem. 22, :3190-3198. https://doi.org/10.1002/cbic.202100380., DOI: 10.1002/cbic.202100380", "listPosition" : 71, "doi" : "10.1002/cbic.202100380", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934324, "link" : "/api/reference/40934324", "label" : "72. Notni 2012: Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET., EJNMMI. Res., 2, p. 28, DOI: 10.1186/2191-219X-2-28", "listPosition" : 72, "doi" : "10.1186/2191-219X-2-28", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934325, "link" : "/api/reference/40934325", "label" : "73. O' Callaghan, G., Houston, A 2015: Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?., Br. J. Pharmacol., 172, p. 5239, DOI: 10.1111/bph.13331", "listPosition" : 73, "doi" : "10.1111/bph.13331", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934326, "link" : "/api/reference/40934326", "label" : "74. Ohtani 1989: Differential effects of alpha-, beta- and gamma-cyclodextrins on human erythrocytes., Eur. J. Biochem., 186, p. 17, DOI: 10.1111/j.1432-1033.1989.tb15171.x", "listPosition" : 74, "doi" : "10.1111/j.1432-1033.1989.tb15171.x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934327, "link" : "/api/reference/40934327", "label" : "75. Ory 2017: Intrathecal 2-Hydroxypropyl-β-Cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick Disease, Type C1: A Non-Randomised, Open-Label, Phase 1–2 Trial., Lancet., 390, p. 1758, DOI: 10.1016/S0140-6736(17)31465-4", "listPosition" : 75, "doi" : "10.1016/S0140-6736(17)31465-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934328, "link" : "/api/reference/40934328", "label" : "76. Pajatsch 1998: Enzymatic preparation of radiolabeled linear maltodextrins and cyclodextrins of high specific activity from [14C] maltose using amylomaltase, cyclodextrin glucosyltransferase and cyclodextrinase., Carbohydr. Res., 307, p. 375, DOI: 10.1016/S0008-6215(97)10113-6", "listPosition" : 76, "doi" : "10.1016/S0008-6215(97)10113-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934329, "link" : "/api/reference/40934329", "label" : "77. Perrin 1978: beta-Cyclodextrin as an aid to peritoneal dialysis. Renal toxicity of beta-cyclodextrin in the rat., Res. Commun. Chem. Pathol. Pharmacol., 19, p. 373", "listPosition" : 77, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934330, "link" : "/api/reference/40934330", "label" : "78. Phelps 2000: PET: the merging of biology and imaging into molecular imaging., J. Nucl. Med., 41, p. 661", "listPosition" : 78, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934331, "link" : "/api/reference/40934331", "label" : "79. Plazzo 2012: Uptake of a fluorescent methyl-β-cyclodextrin via clathrin-dependent endocytosis., Chem. Phys. Lipids., 165, p. 505, DOI: 10.1016/j.chemphyslip.2012.03.007", "listPosition" : 79, "doi" : "10.1016/j.chemphyslip.2012.03.007", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934332, "link" : "/api/reference/40934332", "label" : "80. Pontikis 2013: Cyclodextrin alleviates neuronal storage of cholesterol in Niemann-Pick C disease without evidence of detectable blood-brain barrier permeability., J. Inherit. Metab. Dis., 36, p. 491, DOI: 10.1007/s10545-012-9583-x", "listPosition" : 80, "doi" : "10.1007/s10545-012-9583-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934333, "link" : "/api/reference/40934333", "label" : "81. Prajapati 2021: Cytotoxicity of β-Cyclodextrins in Retinal Explants for Intravitreal Drug Formulations., Molecules., 26, p. 1492, DOI: 10.3390/molecules26051492", "listPosition" : 81, "doi" : "10.3390/molecules26051492", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934334, "link" : "/api/reference/40934334", "label" : "82. Prata 2012: Gallium-68: a new trend in PET radiopharmacy., Curr. Radiopharm., 5, p. 142, DOI: 10.2174/1874471011205020142", "listPosition" : 82, "doi" : "10.2174/1874471011205020142", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934335, "link" : "/api/reference/40934335", "label" : "83. Racz 2018: A non-retinoid antagonist of retinol-binding protein 4 rescues phenotype in a model of Stargardt disease without inhibiting the visual cycle., J. Biol. Chem., 293, p. 11574, DOI: 10.1074/jbc.RA118.002062", "listPosition" : 83, "doi" : "10.1074/jbc.RA118.002062", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934336, "link" : "/api/reference/40934336", "label" : "84. Rajewski 1996: Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery., J. Pharm. Sci., 85, p. 1142, DOI: 10.1021/js960075u", "listPosition" : 84, "doi" : "10.1021/js960075u", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934337, "link" : "/api/reference/40934337", "label" : "85. Ramachandra 2021: Cholesterol homeostasis in the vertebrate retina: biology and pathobiology., J. Lipid. Res., 62", "listPosition" : 85, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934338, "link" : "/api/reference/40934338", "label" : "86. Raz 1972: Interaction of prostaglandins with blood plasma proteins: I. Binding of prostaglandin E2 to human plasma proteins and its effect on the physiological activity of prostaglandin E2 in vitro and in vivo., Biochim. Biophys. Acta. (BBA) – Lipids and Lipid Metabolism., 280, p. 602, DOI: 10.1016/0005-2760(72)90140-3", "listPosition" : 86, "doi" : "10.1016/0005-2760(72)90140-3", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934339, "link" : "/api/reference/40934339", "label" : "87. Ren 2015: In silico understanding of the cyclodextrin-phenanthrene hybrid assemblies in both aqueous medium and bacterial membranes., J Hazard Mater., 285, p. 148, DOI: 10.1016/j.jhazmat.2014.12.001", "listPosition" : 87, "doi" : "10.1016/j.jhazmat.2014.12.001", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934340, "link" : "/api/reference/40934340", "label" : "88. Réti-Nagy 2015: Endocytosis of fluorescent cyclodextrins by intestinal Caco-2 cells and its role in paclitaxel drug delivery., Int. J. Pharm., 496, p. 509, DOI: 10.1016/j.ijpharm.2015.10.049", "listPosition" : 88, "doi" : "10.1016/j.ijpharm.2015.10.049", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934341, "link" : "/api/reference/40934341", "label" : "89. Róka 2015: Evaluation of the Cytotoxicity of α-Cyclodextrin Derivatives on the Caco-2 Cell Line and Human Erythrocytes., Molecules., 20, p. 20269, DOI: 10.3390/molecules201119694", "listPosition" : 89, "doi" : "10.3390/molecules201119694", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934342, "link" : "/api/reference/40934342", "label" : "90. Sauer 2017: A Novel Approach for the Control of Inflammatory Pain: Prostaglandin E2 Complexation by Randomly Methylated β-Cyclodextrins., Anesth. Analg., 124, p. 675, DOI: 10.1213/ANE.0000000000001674", "listPosition" : 90, "doi" : "10.1213/ANE.0000000000001674", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934343, "link" : "/api/reference/40934343", "label" : "91. Schöffer 2017: Effects of immobilization, pH and reaction time in the modulation of α-, β- or γ-cyclodextrins production by cyclodextrin glycosyltransferase: Batch and continuous process., Carbohydr. Polym., 169, p. 41, DOI: 10.1016/j.carbpol.2017.04.005", "listPosition" : 91, "doi" : "10.1016/j.carbpol.2017.04.005", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934344, "link" : "/api/reference/40934344", "label" : "92. Schuhmacher 1995: Multistep tumor targeting in nude mice using bispecific antibodies and a gallium chelate suitable for immunoscintigraphy with positron emission tomography., Cancer. Res., 55, p. 115", "listPosition" : 92, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934345, "link" : "/api/reference/40934345", "label" : "93. Sembo-Backonly 2021: Cyclodextrins: promising scaffolds for MRI contrast agents., RSC. Adv., 11, p. 29762, DOI: 10.1039/D1RA04084G", "listPosition" : 93, "doi" : "10.1039/D1RA04084G", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934346, "link" : "/api/reference/40934346", "label" : "94. Sheng 1997: A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells., Gastroenterology., 113, p. 1883, DOI: 10.1016/S0016-5085(97)70007-6", "listPosition" : 94, "doi" : "10.1016/S0016-5085(97)70007-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934347, "link" : "/api/reference/40934347", "label" : "95. Sheng 1998: Induction of cyclooxygenase-2 by activated Ha-ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway., J. Biol. Chem., 273, p. 22120, DOI: 10.1074/jbc.273.34.22120", "listPosition" : 95, "doi" : "10.1074/jbc.273.34.22120", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934348, "link" : "/api/reference/40934348", "label" : "96. Sheng 2001: K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1., Cancer Res., 61, p. 2670", "listPosition" : 96, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934349, "link" : "/api/reference/40934349", "label" : "97. Shepelytskyi 2020: Cyclodextrin-Based Contrast Agents for Medical Imaging., Molecules., 25, p. 5576, DOI: 10.3390/molecules25235576", "listPosition" : 97, "doi" : "10.3390/molecules25235576", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934350, "link" : "/api/reference/40934350", "label" : "98. Silvestro 2021: The Moringin/α-CD Pretreatment Induces Neuroprotection in an In Vitro Model of Alzheimer's Disease: A Transcriptomic Study., Curr. Issues. Mol. Biol., 43, p. 197, DOI: 10.3390/cimb43010017", "listPosition" : 98, "doi" : "10.3390/cimb43010017", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934351, "link" : "/api/reference/40934351", "label" : "99. Singh 2002: Biotechnological applications of cyclodextrins., Biotechnol. Adv., 20, p. 341, DOI: 10.1016/S0734-9750(02)00020-4", "listPosition" : 99, "doi" : "10.1016/S0734-9750(02)00020-4", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934352, "link" : "/api/reference/40934352", "label" : "100. Smith-Jones 1994: Gallium-67/gallium-68-[DFO]-octreotide–a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies., J. Nucl. Med., 35, p. 317", "listPosition" : 100, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934353, "link" : "/api/reference/40934353", "label" : "101. Stella 2008: Cyclodextrins., Toxicol. Pathol., 36, p. 30, DOI: 10.1177/0192623307310945", "listPosition" : 101, "doi" : "10.1177/0192623307310945", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934354, "link" : "/api/reference/40934354", "label" : "102. Su 2013: Amphiphilic starlike dextran wrapped superparamagnetic iron oxide nanoparticle clsuters as effective magnetic resonance imaging probes., Biomaterials., 34, p. 1193, DOI: 10.1016/j.biomaterials.2012.10.056", "listPosition" : 102, "doi" : "10.1016/j.biomaterials.2012.10.056", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934355, "link" : "/api/reference/40934355", "label" : "103. Sun 2013: Construction of a Supramolecular Polymer by Bridged Bis(permethyl-β-cyclodextrin)s with Porphyrins and Its Highly Efficient Magnetic Resonance Imaging., Macromolecules., 46, p. 4268, DOI: 10.1021/ma400806s", "listPosition" : 103, "doi" : "10.1021/ma400806s", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934356, "link" : "/api/reference/40934356", "label" : "104. Suominen 2017: Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models., Clin. Cancer. Res., 23, p. 4335, DOI: 10.1158/1078-0432.CCR-16-2955", "listPosition" : 104, "doi" : "10.1158/1078-0432.CCR-16-2955", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934357, "link" : "/api/reference/40934357", "label" : "105. Szabó 2022: In vivo assessment of tumor targeting potential of 68Ga-labelled randomly methylated beta-cyclodextrin (RAMEB) and 2-hydroxypropyl-β-cyclodextrin (HPβCD) using positron emission tomography., Int. J. Pharm., 630", "listPosition" : 105, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934358, "link" : "/api/reference/40934358", "label" : "106. Szejtli 1982: Cyclodextrins and their inclusion complexes., Academic publisher, Budapest, 34, p. 395", "listPosition" : 106, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934359, "link" : "/api/reference/40934359", "label" : "107. Szejtli 1998: Introduction and General Overview of Cyclodextrin Chemistry., Chem. Rev., 98, p. 1743, DOI: 10.1021/cr970022c", "listPosition" : 107, "doi" : "10.1021/cr970022c", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934360, "link" : "/api/reference/40934360", "label" : "108. Szejtli 1980: Intestinal absorption of 14C-labelled beta-cyclodextrin in rats., Arzneimittelforschung., 30, p. 808", "listPosition" : 108, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934361, "link" : "/api/reference/40934361", "label" : "109. Szente 1999: Highly soluble cyclodextrin derivatives: chemistry, properties, and trends in development., Adv. Drug. Deliv. Rev., 36, p. 17, DOI: 10.1016/S0169-409X(98)00092-1", "listPosition" : 109, "doi" : "10.1016/S0169-409X(98)00092-1", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934362, "link" : "/api/reference/40934362", "label" : "110. Tóth 2012: Radioactive tracer systems., Magyar tudományos akadémia folyóirata., 136", "listPosition" : 110, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934363, "link" : "/api/reference/40934363", "label" : "111. Trencsényi 2017: Comparative preclinical evaluation of 68Ga-NODAGA and 68Ga-HBED-CC conjugated procainamide in melanoma imaging., J. Pharm. Biomed. Anal., 139, p. 54, DOI: 10.1016/j.jpba.2017.02.049", "listPosition" : 111, "doi" : "10.1016/j.jpba.2017.02.049", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934364, "link" : "/api/reference/40934364", "label" : "112. Trencsényi 2020: In vivo preclinical evaluation of the new 68Ga-labeled beta-cyclodextrin in prostaglandin E2 (PGE2) positive tumor model using positron emission tomography., Int. J. Pharm., 576, DOI: 10.1016/j.ijpharm.2019.118954", "listPosition" : 112, "doi" : "10.1016/j.ijpharm.2019.118954", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934365, "link" : "/api/reference/40934365", "label" : "113. Tsang 1993: A gallium-68 radiopharmaceutical that is retained in myocardium: 68Ga[(4,6-MeO2sal)2BAPEN]+., J. Nucl. Med., 34, p. 1127", "listPosition" : 113, "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934366, "link" : "/api/reference/40934366", "label" : "114. Uekama 1998: Cyclodextrin Drug Carrier Systems., Chem. Rev., 98, p. 2045, DOI: 10.1021/cr970025p", "listPosition" : 114, "doi" : "10.1021/cr970025p", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934367, "link" : "/api/reference/40934367", "label" : "115. Van Ommen 2004: Disposition of 14C-alpha-cyclodextrin in germ-free and conventional rats., Regul. Toxicol. Pharmacol., 39, p. 57, DOI: 10.1016/j.yrtph.2004.05.011", "listPosition" : 115, "doi" : "10.1016/j.yrtph.2004.05.011", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934368, "link" : "/api/reference/40934368", "label" : "116. Váradi 2019: Pharmacokinetic Properties of Fluorescently Labelled Hydroxypropyl-Beta-Cyclodextrin., Biomolecules., 9, p. 509, DOI: 10.3390/biom9100509", "listPosition" : 116, "doi" : "10.3390/biom9100509", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934369, "link" : "/api/reference/40934369", "label" : "117. Varan 2014: Development of implantable hydroxypropylβ-cyclodextrin coated polycaprolactone nanoparticles for the controlled delivery of docetaxel to solid tumors., J. Incl. Phenom. Macrocycl. Chem., 80, p. 9, DOI: 10.1007/s10847-014-0422-6", "listPosition" : 117, "doi" : "10.1007/s10847-014-0422-6", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934370, "link" : "/api/reference/40934370", "label" : "118. Wang 2020: Cyclodextrin Complexation for Enhanced Stability and Non-invasive Pulmonary Delivery of Resveratrol-Applications in Non-small Cell Lung Cancer Treatment., AAPS. PharmSciTech., 21, p. 1, DOI: 10.1208/s12249-020-01724-x", "listPosition" : 118, "doi" : "10.1208/s12249-020-01724-x", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934371, "link" : "/api/reference/40934371", "label" : "119. Wei 2011: Confocal laser scanning microscopy (CLSM) based evidence for cell permeation by mono-4-(N-6-deoxy-6-amino-β-cyclodextrin)-7-nitrobenzofuran (NBD-β-CyD)., Int. J. Pharm., 403, p. 15, DOI: 10.1016/j.ijpharm.2010.09.032", "listPosition" : 119, "doi" : "10.1016/j.ijpharm.2010.09.032", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934372, "link" : "/api/reference/40934372", "label" : "120. Weissleder, R., Wittenberg, J., Harisinghani, M.G., 2011. Chapter 14-Imaging Physics. in: Weissleder, R., Wittenberg, J., Harisinghani, M.G., Chen, J.W., (Eds.), Primer of Diagnostic Imaging (Fifth Edition),Elsevier, Mosby, Norway, pp. 690-746. https://doi.org/10.1016/B978-0-323-06538-2.00014-7., DOI: 10.1016/B978-0-323-06538-2.00014-7", "listPosition" : 120, "doi" : "10.1016/B978-0-323-06538-2.00014-7", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934373, "link" : "/api/reference/40934373", "label" : "121. Wong 2020: Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer's Disease., Sci. Rep., 10, p. 3654, DOI: 10.1038/s41598-020-60293-y", "listPosition" : 121, "doi" : "10.1038/s41598-020-60293-y", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934374, "link" : "/api/reference/40934374", "label" : "122. Yang 2010: Formulation of 68Ga BAPEN kit for myocardial positron emission tomography imaging and biodistribution study., Nucl. Med. Biol., 37, p. 149, DOI: 10.1016/j.nucmedbio.2009.10.010", "listPosition" : 122, "doi" : "10.1016/j.nucmedbio.2009.10.010", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934375, "link" : "/api/reference/40934375", "label" : "123. Ye 2012: Facile synthesis and in vivo evaluation of biodegradable dendritic MRI contrast agents., J. Mater. Chem., 22, p. 14369, DOI: 10.1039/c2jm32211k", "listPosition" : 123, "doi" : "10.1039/c2jm32211k", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934376, "link" : "/api/reference/40934376", "label" : "124. Yoshida 1988: Improvement of chemical instability of digitoxin in aqueous solution by complexation with beta-cyclodextrin derivatives., Chem. Pharm. Bull. (Tokyo), 36, p. 4075, DOI: 10.1248/cpb.36.4075", "listPosition" : 124, "doi" : "10.1248/cpb.36.4075", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934377, "link" : "/api/reference/40934377", "label" : "125. Zhang 2000: Posttranscriptional regulation of cyclooxygenase-2 in rat intestinal epithelial cells., Neoplasia., 2, p. 523, DOI: 10.1038/sj.neo.7900117", "listPosition" : 125, "doi" : "10.1038/sj.neo.7900117", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934378, "link" : "/api/reference/40934378", "label" : "126. Zhang 2017: Synthesis and evaluation of 18F-labeled CJ-042794 for imaging prostanoid EP4 receptor expression in cancer with positron emission tomography., Bioorg. Med. Chem. Lett., 27, p. 2094, DOI: 10.1016/j.bmcl.2017.03.078", "listPosition" : 126, "doi" : "10.1016/j.bmcl.2017.03.078", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934379, "link" : "/api/reference/40934379", "label" : "127. Zhernosekov 2007: Processing of generator-produced 68Ga for medical application., J. Nucl. Med., 48, p. 1741, DOI: 10.2967/jnumed.107.040378", "listPosition" : 127, "doi" : "10.2967/jnumed.107.040378", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934380, "link" : "/api/reference/40934380", "label" : "128. Zhou 2015: Gd3+-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic-2-hydroxypropyl-β-cyclodextrin/Pluronic Polyrotaxane as a Long Circulating High Relaxivity MRI Contrast Agent., ACS. Appl. Mater. Interfaces., 7, p. 22272, DOI: 10.1021/acsami.5b05393", "listPosition" : 128, "doi" : "10.1021/acsami.5b05393", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934381, "link" : "/api/reference/40934381", "label" : "129. Zhou 2016: A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging., Biomaterials., 85, p. 168, DOI: 10.1016/j.biomaterials.2016.02.002", "listPosition" : 129, "doi" : "10.1016/j.biomaterials.2016.02.002", "published" : false, "snippet" : true }, { "otype" : "Reference", "mtid" : 40934382, "link" : "/api/reference/40934382", "label" : "130. Zhou 2017: Enhancing MRI of liver metastases with a zwitterionized biodegradable dendritic contrast agent., Biomater. Sci., 5, p. 1588, DOI: 10.1039/C7BM00126F", "listPosition" : 130, "doi" : "10.1039/C7BM00126F", "published" : false, "snippet" : true } ], "hasCitationDuplums" : false, "userChangeableUntil" : "2023-08-01T10:07:48.147+0000", "directInstitutesForSort" : "Gyógyszertechnológiai Tanszék (DE / GYTK); Gyógyszerésztudományi Kar (DE); Nukleáris Medicina Tanszék (DE / ÁOK / OKI); Orvosi Képalkotó Intézet (DE / ÁOK)", "ownerAuthorCount" : 4, "ownerInstituteCount" : 27, "directInstituteCount" : 4, "authorCount" : 4, "contributorCount" : 0, "hasQualityFactor" : true, "link" : "/api/publication/33789335", "label" : "Képes Zita et al. Insights into recent preclinical studies on labelled cyclodextrin-based imaging probes: towards a novel oncological era. (2023) INTERNATIONAL JOURNAL OF PHARMACEUTICS 0378-5173 1873-3476 640", "template" : "